Neurotrack
Redwood City
About Neurotrack
Neurotrack is a digital health company on a mission to transform the diagnosis and management of Alzheimer's and other dementias. The company develops turnkey tools for providers that can be easily delivered at scale to facilitate early detection of cognitive impairment and ongoing monitoring of cognitive function. Neurotrack's patient-guided, clinically-validated cognitive assessments work in the clinic or at home to fit any workflow. Neurotrack has published 27 peer-reviewed papers, holds 11 patents on its proprietary technology, and is registered as an FDA Class II medical device. For more information visit neurotrack.com. The company was founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola and is based in Redwood City, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $60.4M
- Last round: Series Unknown (Nov 2022)
- Website: neurotrack.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Mobile Devices, Software
Social Profiles
Canonical: https://fsome.com/organization/neurotrack-65367 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.